Navigation Links
Omeros Announces Publication of Data From Antifibrinolytic Program
Date:2/10/2011

cts than other agents. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 4, 2010. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Licenses Novel Antifibrinolytic Agents
2. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
3. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
4. Omeros to Present at the BioCentury NewsMakers Conference
5. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
6. Omeros Successfully Unlocks Orphan GPCRs
7. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
8. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
9. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
10. Daniel K. Spiegelman Elected to Board of Directors of Omeros
11. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , United States , Sept. 1, ... is pleased to announce that it has entered into definitive ... in the United States in a ... ("Placement") by the issue of 71,500,000 million fully-paid ordinary shares ... The Company has also agreed to grant to ...
(Date:9/1/2015)... , Sept. 1, 2015 Ardelyx, Inc. ... focused on gastrointestinal and cardio-renal diseases, today announced ... the option and license agreement for Ardelyx,s portfolio ... was no payment associated with termination and the ... Ardelyx and Sanofi entered into an option and ...
(Date:9/1/2015)... Konica Minolta Medical Imaging announced today the ... to deliver enterprise level imaging to community hospitals, clinics ... as the Konica Minolta AeroDR wireless flat panel detector, ... CR to DR. The SIGMA II CS-7s CR system ... unparalleled reliability and high capacity to help maximize patient ...
Breaking Medicine Technology:Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2
... ... treatment, Dr. Carl Giordano - based in Morristown - among first surgeons ... ... N.J., July 29 Leading New Jersey orthopedic,surgeon Dr. Carl Giordano, of Morristown-based Atlantic ...
... Md., July 29 Micromet, Inc.,(Nasdaq: MITI ... the treatment of cancer, inflammation and autoimmune,diseases, today ... and audio,webcast on Thursday, August 7, 2008, at ... to discuss its second quarter 2008 financial,results. Micromet ...
Cached Medicine Technology:NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 3
(Date:9/1/2015)... ... September 01, 2015 , ... The ... the treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, ... while also demonstrating its safety when used at home to combat hair loss. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy ... their partnership with Apex Physical Therapy (Apex) is official as of ... kind, compassionate, and empathetic care to local residents from their combined eight locations ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th ... Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each ... whom work for Calvary, and two junior counselors who were campers themselves just a ...
Breaking Medicine News(10 mins):Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3
... High Commission organized a seminar to explore the possibility ... ventures in services and manufacturing. They invited the // ... lead the discussion with Indian partners in Chennai on ... Hawkins and the group had discussion with healthcare providers ...
... to enable the smooth transfer of microorganisms and biological ... sign for Indian bioscience. But slow implementation of the ... to become the global hub of contract research and ... major player. , ,Discussions in mid-June between acting ...
... HIV during pregnancy because of their own or ... physiological changes during gestation. Irrespective of the mechanism ... HIV acquisition are significantly higher during pregnancy than ... HIV prevention, both to protect mothers from primary ...
... the Indraprastha Apollo Hospital in New Delhi expressed hope that ... successfully separated. // , ,The twins who are joined ... and doctors say that a major impediment to the surgery ... drainage vessel in the brain. Another possible roadblock is the ...
... his/her HIV status, but as far as law goes, you ... the fact that you have to rely on the quality ... ,The Wellington District Court, New Zealand, dismissed the charges of ... nuisance after not disclosing to his female partner his HIV ...
... by Sanofi Pasteur and Merck and found to be ... three doses over 6 months which has shown 100% successful. The ... vaccine protects against Human Papilloma virus infection and also genital warts, ... the market early next year and the profits would be great, ...
Cached Medicine News:Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:Women might be at increased risk of HIV during pregnancy 2Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:Gardasil vaccine for cervical cancer 2